VX-264 — catalyst calendar

1 verified catalyst event(s) referencing VX-264, each linked to its official source. Verified as of 2026-11-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03-12
in 4mo
ESTIMATED
READOUT
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1
Phase 1/2 · Type 1 Diabetes
Vertex Pharmaceuticals Incorporate VX-264 ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.